The Aeon Team
Dr. Ann Elsner, PhD
Aeon Imaging was founded by Dr. Elsner in 2005, where she currently serves as its Chief Executive Officer. Dr. Elsner is a tenured professor at the Indiana University School of Optometry, has >20 years of experience developing retinal imaging technology, and is the lead inventor of Aeon's core intellectual property.
Mr. Matthew Muller, MS, MBA
Mr. Muller currently serves as Aeon's Chief Operating Officer and Director of its Ocular Disease Screening Division. With a background in optical engineering, Mr. Muller performs camera design and development, as well as the day-to-day management of the company.
Dr. Benno L. Petrig, DSc
Dr. Petrig currently serves as Aeon's Chief Scientific Officer and Director of its Low Vision Assessment Division, in addition to his position as a Senior Scientist at the Indiana University School of Optometry. He has >30 years of experience developing ocular blood flow measurement instrumentation for eye researchers and the eye care industry and designs and develops the camera electronic systems.
Dr. Tom Gast, MD, PhD
Dr. Gast currently serves as Aeon's Chief Medical Officer. He has >10 years experience as an ophthalmologist in private practice and provides image analysis and guidance on retinal function and disease.
Mr. Tim Hall, BAS
Mr. Hall currently serves as Aeon's Engineering Technician. His background is in mechanical design and engineering technology and he designs and develops the alignment base, chin rest and enclosure.
Mr. Jeff Clendenon, BSE
Mr. Clendenon currently serves as Aeon's Software Engineer. He has >30 years experience programming biomedical imaging analysis software, and he develops the image processing and graphical user interface code.
Mr. Andrew Stanfield, BS
Mr. Stanfield currently serves as Aeon’s Marketing Specialist. His background is in online marketing and sales. He is involved in developing the company website, marketing, and other business management responsibilities.
Financial Conflict of Interest Regulations
Aeon Imaging receives research and development funding from Small Business Innovation Research (SBIR) grants awarded by the National Institutes of Health (NIH). As such, it is subject to the 2011 Revised Regulations of the Responsibility of Applicants for Promoting Objectivity in Research for which PHS Funding is Sought (42 CFR Part 50 Subpart F)
The 2011 Revised Regulations promote objectivity in research by establishing standards that provide a reasonable expectation that the design, conduct, and reporting of research performed under NIH grants or cooperative agreements will be free from bias resulting from Investigator financial conflicts of interest.
Aeon Imaging's policy on Financial Conflict of Interest (FCOI) is to report all financial conflicts of interest that meet the 2011 Revised Regulations definition of a "Significant Financial Interest" to the NIH. New FCOIs are reported within 30 days of discovery of a new significant financial interest. The FCOIs of all investigators are reviewed prior to submission of NIH-funded research applications, and are reviewed annually, or as stipulated by the terms of an NIH grant award. Every member of the Aeon Imaging team who is an investigator on a NIH-funded research grant is made aware of the FCOI regulations and is required to sign a form indicating whether or not a significant financial interest exists. Every investigator with a significant financial interest is subject to a FCOI management plan, which discloses the investigator's role, the financial interest, the conditions designed to safeguard objectivity in research, and how the management plan will be monitored to ensure compliance. FCOI management plans are filed with the NIH at the time of the disclosure.
Financial Conflict of Interest Disclosures
| Investigator |
NIH Grant Number(s) |
Project Role |
Significant Financial Interest Entity |
Nature of Financial Interest |
Approximate Dollar Amount |
| Ann E. Elsner, PhD |
EY020017
EY018772
EB014805 |
Research Project Design |
Indiana University |
Salary plus fringe benefits earned from Entity |
$100,000 - $150,000 |
| Benno L. Petrig, DSc |
EY018772 |
Principal Investigator |
Indiana University |
Salary plus fringe benefits earned from Entity |
$60,000 - $80,000 |
| Benno L. Petrig, DSc |
EY020017
EB014805 |
Electronics Development |
Indiana University |
Salary plus fringe benefits earned from Entity |
$60,000 - $80,000 |
